Previous Article | Next Article 
Journal of Virology, April 2002, p. 3105-3113, Vol. 76, No. 7
0022-538X/02/$04.00+0 DOI: 10.1128/JVI.76.7.3105-3113.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Efficient Concerted Integration by Recombinant Human Immunodeficiency Virus Type 1 Integrase without Cellular or Viral Cofactors
Sapna Sinha, Michael H. Pursley, and Duane P. Grandgenett*
Institute for Molecular Virology, St. Louis University Health Sciences Center, St. Louis, Missouri 63110
Received 24 October 2001/
Accepted 21 December 2001
Replication of retroviruses requires integration of the linear viral DNA genome into the host chromosomes. Integration requires the viral integrase (IN), located in high-molecular-weight nucleoprotein complexes termed preintegration complexes (PIC). The PIC inserts the two viral DNA termini in a concerted manner into chromosomes in vivo as well as exogenous target DNA in vitro. We reconstituted nucleoprotein complexes capable of efficient concerted (full-site) integration using recombinant wild-type human immunodeficiency virus type I (HIV-1) IN with linear retrovirus-like donor DNA (480 bp). In addition, no cellular or viral protein cofactors are necessary for purified bacterial recombinant HIV-1 IN to mediate efficient full-site integration of two donor termini into supercoiled target DNA. At
30 nM IN (20 min at 37°C), approximately 15 and 8% of the input donor is incorporated into target DNA, producing half-site (insertion of one viral DNA end per target) and full-site integration products, respectively. Sequencing the donor-target junctions of full-site recombinants confirms that 5-bp host site duplications have occurred with a fidelity of
70%, similar to the fidelity when using IN derived from nonionic detergent lysates of HIV-1 virions. A key factor allowing recombinant wild-type HIV-1 IN to mediate full-site integration appears to be the avoidance of high IN concentrations in its purification (
125 µg/ml) and in the integration assay (<50 nM). The results show that recombinant HIV-1 IN may not be significantly defective for full-site integration. The findings further suggest that a high concentration or possibly aggregation of IN is detrimental to the assembly of correct nucleoprotein complexes for full-site integration.
* Corresponding author. Mailing address: Institute for Molecular Virology, St. Louis University Health Sciences Center, 3681 Park Ave., St. Louis, MO 63110. Phone: (314) 577-8411. Fax: (314) 577-8406. E-mail: Grandgdp{at}SLU.EDU.
Journal of Virology, April 2002, p. 3105-3113, Vol. 76, No. 7
0022-538X/02/$04.00+0 DOI: 10.1128/JVI.76.7.3105-3113.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Zahm, J. A., Bera, S., Pandey, K. K., Vora, A., Stillmock, K., Hazuda, D., Grandgenett, D. P.
(2008). Mechanisms of Human Immunodeficiency Virus Type 1 Concerted Integration Related to Strand Transfer Inhibition and Drug Resistance. Antimicrob. Agents Chemother.
52: 3358-3368
[Abstract]
[Full Text]
-
Ebina, H., Chatterjee, A. G., Judson, R. L., Levin, H. L.
(2008). The GP(Y/F) Domain of TF1 Integrase Multimerizes when Present in a Fragment, and Substitutions in This Domain Reduce Enzymatic Activity of the Full-length Protein. J. Biol. Chem.
283: 15965-15974
[Abstract]
[Full Text]
-
Malet, I., Delelis, O., Valantin, M.-A., Montes, B., Soulie, C., Wirden, M., Tchertanov, L., Peytavin, G., Reynes, J., Mouscadet, J.-F., Katlama, C., Calvez, V., Marcelin, A.-G.
(2008). Mutations Associated with Failure of Raltegravir Treatment Affect Integrase Sensitivity to the Inhibitor In Vitro. Antimicrob. Agents Chemother.
52: 1351-1358
[Abstract]
[Full Text]
-
Zhao, Z., McKee, C. J., Kessl, J. J., Santos, W. L., Daigle, J. E., Engelman, A., Verdine, G., Kvaratskhelia, M.
(2008). Subunit-specific Protein Footprinting Reveals Significant Structural Rearrangements and a Role for N-terminal Lys-14 of HIV-1 Integrase during Viral DNA Binding. J. Biol. Chem.
283: 5632-5641
[Abstract]
[Full Text]
-
Pandey, K. K., Bera, S., Zahm, J., Vora, A., Stillmock, K., Hazuda, D., Grandgenett, D. P.
(2007). Inhibition of Human Immunodeficiency Virus Type 1 Concerted Integration by Strand Transfer Inhibitors Which Recognize a Transient Structural Intermediate. J. Virol.
81: 12189-12199
[Abstract]
[Full Text]
-
Dicker, I. B., Samanta, H. K., Li, Z., Hong, Y., Tian, Y., Banville, J., Remillard, R. R., Walker, M. A., Langley, D. R., Krystal, M.
(2007). Changes to the HIV Long Terminal Repeat and to HIV Integrase Differentially Impact HIV Integrase Assembly, Activity, and the Binding of Strand Transfer Inhibitors. J. Biol. Chem.
282: 31186-31196
[Abstract]
[Full Text]
-
Pandey, K. K., Sinha, S., Grandgenett, D. P.
(2007). Transcriptional Coactivator LEDGF/p75 Modulates Human Immunodeficiency Virus Type 1 Integrase-Mediated Concerted Integration. J. Virol.
81: 3969-3979
[Abstract]
[Full Text]
-
Desfarges, S., San Filippo, J., Fournier, M., Calmels, C., Caumont-Sarcos, A., Litvak, S., Sung, P., Parissi, V.
(2006). Chromosomal integration of LTR-flanked DNA in yeast expressing HIV-1 integrase: down regulation by RAD51. Nucleic Acids Res
34: 6215-6224
[Abstract]
[Full Text]
-
Guiot, E., Carayon, K., Delelis, O., Simon, F., Tauc, P., Zubin, E., Gottikh, M., Mouscadet, J.-F., Brochon, J.-C., Deprez, E.
(2006). Relationship between the Oligomeric Status of HIV-1 Integrase on DNA and Enzymatic Activity. J. Biol. Chem.
281: 22707-22719
[Abstract]
[Full Text]
-
Li, M., Craigie, R.
(2005). Processing of Viral DNA Ends Channels the HIV-1 Integration Reaction to Concerted Integration. J. Biol. Chem.
280: 29334-29339
[Abstract]
[Full Text]
-
Wang, Y., Klock, H., Yin, H., Wolff, K., Bieza, K., Niswonger, K., Matzen, J., Gunderson, D., Hale, J., Lesley, S., Kuhen, K., Caldwell, J., Brinker, A.
(2005). Homogeneous High-Throughput Screening Assays for HIV-1 Integrase 3{beta}-Processing and Strand Transfer Activities. J Biomol Screen
10: 456-462
[Abstract]
-
Sinha, S., Grandgenett, D. P.
(2005). Recombinant Human Immunodeficiency Virus Type 1 Integrase Exhibits a Capacity for Full-Site Integration In Vitro That Is Comparable to That of Purified Preintegration Complexes from Virus-Infected Cells. J. Virol.
79: 8208-8216
[Abstract]
[Full Text]
-
Faure, A.él., Calmels, C., Desjobert, Céc., Castroviejo, M., Caumont-Sarcos, A., Tarrago-Litvak, L., Litvak, S., Parissi, V.
(2005). HIV-1 integrase crosslinked oligomers are active in vitro. Nucleic Acids Res
33: 977-986
[Abstract]
[Full Text]
-
Bischerour, J., Tauc, P., Leh, H., Rocquigny, H. d., Roques, B., Mouscadet, J.-F.
(2003). The (52-96) C-terminal domain of Vpr stimulates HIV-1 IN-mediated homologous strand transfer of mini-viral DNA. Nucleic Acids Res
31: 2694-2702
[Abstract]
[Full Text]
-
Cherepanov, P., Maertens, G., Proost, P., Devreese, B., Van Beeumen, J., Engelborghs, Y., De Clercq, E., Debyser, Z.
(2003). HIV-1 Integrase Forms Stable Tetramers and Associates with LEDGF/p75 Protein in Human Cells. J. Biol. Chem.
278: 372-381
[Abstract]
[Full Text]
-
Gao, K., Gorelick, R. J., Johnson, D. G., Bushman, F.
(2002). Cofactors for Human Immunodeficiency Virus Type 1 cDNA Integration In Vitro. J. Virol.
77: 1598-1603
[Abstract]
[Full Text]
Copyright © 2002 by the American Society for Microbiology. All rights reserved.